Synthesis of Novel Bicyclic Nitroxides Using Partial Favorskii Rearrangement

Andrej Babič; Slavko Pečar

doi:10.1055/s-2008-1072715

LETTER

Synthesis of Novel Bicyclic Nitroxides Using Partial Favorskii Rearrangement

Andrej Babič*^a, Slavko Pečar^a,b
^a Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia
Fax: +386(1)4258031; e-Mail: andrej.babic@ffa.uni-lj.si;
^b Jo˛ef Stefan Institute, Jamova cesta 39, 1000 Ljubljana, Slovenia

Abstract

Alle Artikel dieser Rubrik

Abstract

3-Bromo-2,2,6,6-tetramethyl-4-oxopiperidine-1-oxyl was reacted with several C-nucleophiles to give novel bicyclic pyrrolidine nitroxides through partial Favorskii rearrangement. Further reduction with sodium borohydride gave spin probes with free hydroxyl groups and under harsh reduction conditions allowed the Favorskii rearrangement to proceed to completion.

Key words

bicyclic compounds - rearrangements - nitroxide free radicals - spin probes - ring opening

Volltext

Referenzen

References and Notes

<A NAME="RG02608ST-1">1</A> Kende AS. The Favorskii Rearrangement of Haloketones, In Organic Reactions Vol. 2: John Wiley and Sons; New York: 1960. p.261

<A NAME="RG02608ST-2">2</A> De Kimpe N. Verhe R. Buyck L. Moens L. Schamp N. Tetrahedron Lett. 1981, 22: 1837

<A NAME="RG02608ST-3">3</A> Nagasawa HT. Elberling JA. Tetrahedron Lett. 1969, 44: 5393

<A NAME="RG02608ST-4">4</A> Rozantzev EG. Free Nitroxyl Radicals Plenum Press; New York: 1970. p.204

<A NAME="RG02608ST-5">5</A> Volodarsky LB. Reznikov VA. Ovacharenko VI. Synthetic Chemistry of Stable Nitroxides 40: CRC Press; Boca Raton: 1994. p.89

<A NAME="RG02608ST-6">6</A> Hankovszky OH. Hideg K. Bódi I. Frank L. J. Med. Chem. 1986, 29: 1138

<A NAME="RG02608ST-7">7</A> Rozantzev EG. Krinitzkaya LA. Tetrahedron 1965, 21: 491

<A NAME="RG02608ST-8">8</A> Elas M. Williams BB. Parasca A. Mailer C. Pelizzari CA. Lewis MA. River JN. Karczmar GS. Barth ED. Halpern HJ. Magn. Reson. Med. 2003, 49: 682

<A NAME="RG02608ST-9">9</A> Shen J. Liu S. Miyake M. Liu W. Pritchard A. Kao JPY. Rosen GM. Tong Y. Liu KJ. Magn. Reson. Med. 2006, 55: 1433

<A NAME="RG02608ST-10">10</A> Kao JPY. Barth ED. Burks SR. Smithback P. Mailer C. Ahn K.-H. Halpern HJ. Rosen GM. Magn. Reson. Med. 2007, 58: 850

<A NAME="RG02608ST-11">11</A> Berliner LJ. Spin Labeling Academic Press; New York: 1976. p.274

<A NAME="RG02608ST-12">12</A> Marc G. Pečar S. Synth. Commun. 1995, 25: 1015

<A NAME="RG02608ST-13">13</A> Sosnovsky G. Cai Z. J. Org. Chem. 1995, 60: 3414

<A NAME="RG02608ST-14">14</A> Sakai T. Amano E. Kawabata AA. Takeda A. J. Org. Chem. 1980, 45: 43

<A NAME="RG02608ST-15">15</A> Sakai T. Katayama T. Takeda A. J. Org. Chem. 1981, 46: 2924

<A NAME="RG02608ST-16">16</A> Sakai T. Tabata H. Takeda A. J. Org. Chem. 1983, 48: 4618

<A NAME="RG02608ST-17">17</A> Barbee TR. Hedeel G. Heeg MJ. Albizati KF. J. Org. Chem. 1991, 56: 6773

<A NAME="RG02608ST-18">18</A> De Angelis F. Feroci M. Inesi A. Bull. Soc. Chim. Fr. 1993, 130: 712

<A NAME="RG02608ST-19">19</A> Rappe C. Knutsson L. Turro NJ. Gagosian RB. J. Am. Chem. Soc. 1970, 92: 2032

<A NAME="RG02608ST-20">20</A> House HO. Frank GA. J. Org. Chem. 1965, 30: 2948

<A NAME="RG02608ST-21">21</A> Becker HGO. Organikum Wiley-VCH; Weinheim: 2001. p.608

Typical Procedure for the Synthesis of Products 6a-h
3-Bromo-2,2,6,6-tetramethyl-1-oxyl-piperidine-4-one (1, 400 mg, 1.61 mmol) was dissolved in anhyd THF (20 mL). The sodium salt of the appropriate C-nucleophile was dissolved in anhyd THF (5 mL) and added dropwise to the stirred solution of 1 over a period of 5 min under argon. The reaction mixture was refluxed at 50 °C for 1.5 h. After that time the solvent was evaporated under reduced pressure and the yellow solid dissolved in cold citric acid (10 mL, pH 3.5). The aqueous phase was immediately extracted with EtOAc. The organic phase was washed with brine, dried with Na₂SO₄, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (Et₂O-hexane, 3:1). A bright yellow solid was obtained.

Methyl 2-Cyano-2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}acetate (6g) Yield 37%; yellow solid; mp 120-124 °C. IR (KBr): 3213, 2984, 2257, 1738, 1442, 1306, 1220, 1016, 928, 712 cm^-1. MS (EI): m/z = 267 [M]⁺. ¹H NMR (300 MHz, CDCl₃): δ = 1.28 (s, 2 H, CH), 1.32 (s, 12 H, CH₃), 3.30 (s, 1 H, CH), 3.84 (s, 3 H, COOCH₃) ppm. EPR: a_N = 1.55 mT. Anal. Calcd for C₁₃H₁₉N₂O₄ (%): C, 58.41; H, 7.19; N, 10.48. Found: C, 58.17; H, 7.33; N, 10.71.

Dimethyl 2-{6-Hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl} Malonate (6e) Yield 75%; yellow solid; mp 146-150 °C. IR (KBr): 3442, 2981, 1742, 1438, 1253, 1179, 1011, 914, 715, 624 cm^-1. MS (EI): m/z = 300 [M]⁺. ¹H NMR (300 MHz, CDCl₃): δ = 1.21 (s, 12 H, CH₃), 1.30 (s, 2 H, CH), 3.15 (s, 1 H, CH), 3.67 (s, 6 H, COOCH₃) ppm. ¹³C NMR (75 MHz, CDCl₃): δ = 23.21, 25.36, 31.58, 52.89, 58.09, 61.71, 65.92, 168.32 ppm. EPR: a_N = 1.55 mT. Anal. Calcd for C₁₄H₂₂NO₆ (%): C, 55.98; H, 7.38; N, 4.66. Found: C, 55.78; H, 7.57; N, 4.69.

NMR spectra were obtained after reduction with phenyl hydrazine. The compound was dissolved in perdeuterated solvent, transferred into a NMR tube, and flushed with argon. Phenyl hydrazine (2 equiv) was added and the NMR tube shaken to allow the reduction to proceed to completion prior to the NMR spectroscopic analysis.

Preparation of tert -Butyl 3-Hydroxy-2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl)butanoate} (8) tert-Butyl 2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-3-oxobutanoate (6c) (200 mg, 0.61 mmol) was dissolved in MeOH (10 mL) and cooled to 0 °C. Sodium borohydride (24 mg, 0.61 mmol) was added with stirring. The temperature was maintained at 0 °C for 2 h, after which the reaction was quenched with citric acid and the pH adjusted to 6. The solvents were evaporated under reduced pressure and citric acid (10%) was added to adjust the pH to 3. The water phase was extracted with EtOAc. The organic phase was washed with brine, dried with Na₂SO₄, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (Et₂O-hexane, 3:1). A bright yellow solid was obtained; yield 93%; mp 101-108 °C. IR (KBr): 3460, 2976, 1702, 1477, 1375, 1160, 993, 646 cm^-1. MS (EI): m/z = 328 [M]⁺. MS-FAB: m/z = 330 [M + 2]⁺. HRMS (EI): m/z calcd for C₁₇H₃₀N₁O₅: 328.212398 [MH]⁺; found: 328.213250.

Preparation of 2-{6-Hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-1-phenyl-propane-1,3-diol (7) Ethyl 2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-3-oxo-3-phenylpropanoate (6f, 170 mg, 0.47 mmol) was dissolved in MeOH (10 mL) and cooled to 0 °C. While being stirred, NaBH₄ (42 mg, 1.06 mmol) was added. The same amount of NaBH₄ (42 mg, 0.53 mmol) was again added after 1 h and 2 h. After the third addition the reaction mixture was allowed to warm to ambient temperature. Then, 12 h later, citric acid was added and the pH adjusted to 6. The solvents were evaporated under reduced pressure and citric acid (10%) was added to adjust the pH to 3. The water phase was extracted with EtOAc. The organic phase was washed with brine, dried with Na₂SO₄, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (CH₂Cl₂-MeOH, 15:1). A bright yellow solid was obtained; yield 73%; mp 147-157 °C. IR (KBr): 3421, 2978, 1649, 1457, 1287, 1174, 1032, 705 cm^-1. MS (EI): m/z = 320 [M]⁺. HRMS (EI): m/z calcd for C₁₈H₂₆N₁O₄: 320.186184 [MH⁺]; found: 320.187330.

Preparation of 1-(1-Oxyl-2,2,5,5-tetramethylpyrrolidine-3-yl)-2-hydroxymethyl-3-phenylpropane-1,3-diol (9a)
Ethyl 2-{6-hydroxy-3-oxyl-2,2,4,4-tetramethyl-3-azabicyclo[3.1.0]hex-6-yl}-3-oxo-3-phenylpropanoate (6f, 300 mg, 0.83 mmol) was dissolved in THF (10 mL), and NaBH₄ (148 mg, 3.72 mmol) was added. The reaction mixture was refluxed at 40 °C and MeOH (0.5 mL) was added over 0.5 h. Following the addition of MeOH the temperature was maintained at 40 °C for another 2.5 h. Several drops of H₂O were then added and the solvents evaporated under reduced pressure, giving a bright yellow foam. Citric acid (10%, 10 mL) was added and the water phase extracted with EtOAc after the evolution of hydrogen stopped. The organic phase was washed with brine, dried with Na₂SO₄, and the solvent evaporated under reduced pressure. The crude product was purified using circular chromatography (CH₂Cl₂-MeOH, 15:1). A bright yellow solid was obtained; yield 21%; mp 157-163 °C. IR (KBr): 3290, 2976, 1474, 1411, 1367, 1295, 1257, 1050, 763, 706 cm^-1. MS (EI): m/z = 322 [M]⁺. MS-FAB: m/z = 322 [M]⁺, 324 [M + 2]⁺. HRMS (EI): m/z calcd for C₁₈H₂₈N₁O₄: 322.201834 [M]⁺; found: 322.202650.